Cargando…

A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis

BACKGROUND: Sarcomas are a rare, heterogeneous group of tumors with variable tendencies for aggressive behavior. Molecular markers for prognosis are needed to risk stratify patients and identify those who might benefit from more intensive therapeutic strategies. PATIENTS AND METHODS: We analyzed som...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bui, Nam Q., Przybyl, Joanna, Trabucco, Sally E., Frampton, Garrett, Hastie, Trevor, van de Rijn, Matt, Ganjoo, Kristen N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739971/ https://www.ncbi.nlm.nih.gov/pubmed/31528332 http://dx.doi.org/10.1186/s13569-019-0122-5

Ejemplares similares

Long-Term Remission with Ipilimumab/Nivolumab in Two Patients with Different Soft Tissue Sarcoma Subtypes and No PD-L1 Expression
por: Zhou, Maggie, et al.
Publicado: (2021)

Detection of Circulating Tumor DNA in Patients With Uterine Leiomyomas
por: Przybyl, Joanna, et al.
Publicado: (2019)

Evaluation of Absolute Lymphocyte Count at Diagnosis and Mortality Among Patients With Localized Bone or Soft Tissue Sarcoma
por: Brewster, Ryan, et al.
Publicado: (2021)

Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma
por: Przybyl, Joanna, et al.
Publicado: (2022)

Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas
por: Testa, Stefano, et al.
Publicado: (2022)

Detection of SS18-SSX1/2 fusion transcripts in circulating tumor cells of patients with synovial sarcoma
por: Przybyl, Joanna, et al.
Publicado: (2019)

CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A
por: Tu, Q, et al.
Publicado: (2018)

The role of radiology in paediatric soft tissue sarcomas
por: Park, K., et al.
Publicado: (2008)

Fourteen-Day Gemcitabine-Docetaxel Chemotherapy Is Effective and Safer Compared to 21-Day Regimen in Patients with Advanced Soft Tissue and Bone Sarcoma
por: Pan, Minggui, et al.
Publicado: (2021)

CDKN2A/B Homozygous Deletions in Astrocytomas: A Literature Review
por: Yuile, Alexander, et al.
Publicado: (2023)

CHARACTERIZATION OF ALVEOLAR SOFT PART SARCOMA OF THE TONGUE: A CLINICO-PATHOLOGIC STUDY AND SCOPING REVIEW
por: Akinyamoju, A.O., et al.
Publicado: (2020)

Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis
por: Ortiz, Berenice, et al.
Publicado: (2014)

Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis
por: Testa, Stefano, et al.
Publicado: (2023)

CDKN2 Gene Deletion as Poor Prognosis Predictor Involved in the Progression of Adult B-Lineage Acute Lymphoblastic Leukemia Patients
por: Xu, Na, et al.
Publicado: (2015)

Germline hemizygous deletion of CDKN2A–CDKN2B locus in a patient presenting with Li–Fraumeni syndrome
por: Chan, Sock Hoai, et al.
Publicado: (2016)

Co‐occurrence of CDKN2A/B and IFN‐I homozygous deletions correlates with an immunosuppressive phenotype and poor prognosis in lung adenocarcinoma
por: Peng, Yuan, et al.
Publicado: (2022)

Comorbidity is Independently Associated with Poor Outcome in Extremity Soft Tissue Sarcoma
por: Kang, Seungcheol, et al.
Publicado: (2015)

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma
por: Gounder, Mrinal M., et al.
Publicado: (2022)

Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.
por: Maelandsmo, G. M., et al.
Publicado: (1995)

Uterine sarcoma: Clinico-pathological characteristics and outcome
por: Sait, Hesham K., et al.
Publicado: (2014)

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
por: Sievers, Philipp, et al.
Publicado: (2020)

CDKN2A Deletion Leading to Hematogenous Metastasis of Human Gastric Carcinoma
por: Qiao, Juanli, et al.
Publicado: (2021)

CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)
por: Maura, Francesco, et al.
Publicado: (2020)

First Recurrence of Synovial Sarcoma Presenting With Solitary Pancreatic Mass
por: Narayan, Raja R, et al.
Publicado: (2022)

CDKN2A/CDK4 Status in Greek Patients with Familial Melanoma and Association with Clinico-epidemiological Parameters
por: KARAGIANNI, Fani, et al.
Publicado: (2018)

Cytoplasmic maspin expression predicts poor prognosis of patients with soft tissue sarcomas
por: Takeda, Chikako, et al.
Publicado: (2014)

GATA3 Expression Is a Poor Prognostic Factor in Soft Tissue Sarcomas
por: Haraguchi, Toshiaki, et al.
Publicado: (2016)

Sinonasal FUS-ERG-Rearranged Ewing's Sarcoma Mimicking Glomangiopericytoma
por: Zhou, Maggie, et al.
Publicado: (2020)

Recurrent DMD Deletions Highlight Specific Role of Dp71 Isoform in Soft-Tissue Sarcomas
por: Mauduit, Olivier, et al.
Publicado: (2019)

The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma
por: Lesueur, F, et al.
Publicado: (2008)

Conceptos clínicos y radiológicos del sarcoma osteogénico /
por: Herrera Carrillo, Manuel Fernando
Publicado: (1983)

PARP Inhibitor Insensitivity to BRCA1/2 Monoallelic Mutations in Microsatellite Instability-High Cancers
por: Sokol, Ethan S., et al.
Publicado: (2022)

Pre-Treatment Anemia Is a Poor Prognostic Factor in Soft Tissue Sarcoma Patients
por: Szkandera, Joanna, et al.
Publicado: (2014)

Expression of SIRT1 and DBC1 Is Associated with Poor Prognosis of Soft Tissue Sarcomas
por: Kim, Jung Ryul, et al.
Publicado: (2013)

Integrative Clustering Reveals a Novel Subtype of Soft Tissue Sarcoma With Poor Prognosis
por: Zhu, Zhenhua, et al.
Publicado: (2020)

Early Lymph Node Metastasis May Predict Poor Prognosis in Soft Tissue Sarcoma
por: Emori, Makoto, et al.
Publicado: (2019)

Immunostaining for VEGF and Decorin Predicts Poor Survival and Recurrence in Canine Soft Tissue Sarcoma
por: Bray, Jonathan P., et al.
Publicado: (2023)

Childhood Acute B-Lineage Lymphoblastic Leukemia With CDKN2A/B Deletion Is a Distinct Entity With Adverse Genetic Features and Poor Clinical Outcomes
por: Feng, Jing, et al.
Publicado: (2022)

Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinoma
por: Fan, Chao, et al.
Publicado: (2015)

Epstein Barr Virus-Positive Lymphoproliferative Disorder Following Lymphodepletion for MAGE A4 Adoptive Cellular Therapy in a Patient with Synovial Sarcoma: A Case Report
por: Zhou, Maggie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ckutmn48dchnesjdn3ne5bn31m